
Jennifer Lim
Articles
-
Nov 5, 2024 |
healio.com | Jennifer Lim |Michela Cimberle |Christine Klimanskis
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Jennifer I. Lim, MD, speaks about the impact of early fluid reduction with anti-VEGF therapy in diabetic macular edema.
-
Sep 27, 2024 |
healio.com | Jennifer Lim |Michela Cimberle |Christine Klimanskis
Read more You've successfully added Retina/Vitreous in Ophthalmology to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Jennifer I.
-
Jun 6, 2024 |
healio.com | Jennifer Lim |Anthony DeFino |Christine Klimanskis
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. SEATTLE — In this Healio Video Perspective from the ARVO meeting, Jennifer I. Lim, MD, discusses anti-VEGF therapy for the treatment of proliferative sickle cell retinopathy.
-
May 6, 2024 |
healio.com | Jennifer Lim |Anthony DeFino |Christine Klimanskis
Read more You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. SEATTLE — In this Healio Video Perspective from the ARVO meeting, Jennifer I. Lim, MD, discusses anti-VEGF therapy for the treatment of proliferative sickle cell retinopathy.
-
Feb 27, 2024 |
medrxiv.org | Rashadul Hasan Badhon |Jennifer Lim |Theodore Leng |Atalie Carina Thompson
The authors have declared no competing interest. This study was funded by NEI R15EY035804 (MNA) and UNC Charlotte Faculty Research Grant (MNA)I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →